XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 19, 2019
Dec. 31, 2019
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (24,781) $ (31,935) $ (68,522) $ (287,977)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:        
Depreciation and amortization 1,989 19,606 22,468 24,453
Goodwill and tradename intangible assets impairment       190,777
Stock-based compensation   20,683 10,646 4,950
Amortization of deferred financing costs 213 841 1,026 1,026
Warrant issuance costs       1,386
Change in fair value of warrant liabilities   19,700 2,600 6,100
Provision for doubtful accounts 8   453 172
Inventories impairment charges     3,977 6,000
Loss from write-offs of property and equipment     177 90
Loss on extinguishment of debt 3,413      
Deferred income taxes (9) (643) 89 1,575
Changes in:        
Accounts receivable 1,671 (6,840) (16,939) 27,347
Inventories (406) 352 (6,260) 2,866
Prepaid expenses 1,073 (1,714) 376 705
Other current assets 213 (776) 1,013 725
Other non-current assets (1,003) (854) 375 (2,974)
Accounts payable 8,313 7,529 7,245 (14,836)
Accounts payable – related parties (6,553)      
Accrued expenses 19,792 (30,078) 6,471 1,538
Other current liabilities (288) 317 (94) (139)
Income taxes payable 42 409   (900)
Income tax contingency   69 (263) 443
Deferred rent 37 160 58 123
Net cash (used in) provided by operating activities 3,733 (3,174) (35,104) (36,550)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Capital expenditures (517) (2,909) (2,868) (2,132)
Acquisition of OSW Predecessor, net of cash acquired   (676,453)    
Net cash used in investing activities (517) (679,362) (2,868) (2,132)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from the issuance of common shares   122,510    
Net proceeds from Haymaker and private placement investors   349,390    
Proceeds from 2020 private placement, net of issuance costs paid       68,602
Proceeds from At-the Market Equity Offering, net of issuance costs paid     27,474 11,090
Proceeds from the term loan and revolver facilities   245,900   20,000
Dividend paid on common stock       (2,445)
Purchase of public warrants       (879)
Proceeds from conversion of public warrants into common shares   11    
Payment of deferred financing costs   (6,892)    
Repayment on term loan and revolver facilities   (18,442)   (13,000)
Proceeds from amounts due from related party   3,187    
Net distributions to Parent and its affiliates (4,262)      
Distributions to noncontrolling interest (267) (834)   (4,011)
Cash paid to acquire noncontrolling interest       (10,810)
Net cash provided by (used in) financing activities (4,529) 694,830 27,474 68,547
Effect of exchange rate changes on cash 649 (205) (117) (280)
Net (decrease) increase in cash and cash equivalents and restricted cash (664) 12,089 (10,615) 29,585
Cash and cash equivalents and restricted cash, Beginning of period 15,302 1,774 43,448 13,863
Cash and cash equivalents and restricted cash, End of period 14,638 13,863 32,833 43,448
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:        
Income taxes 73 409 160 115
Interest   12,347 $ 12,567 11,730
Non-cash transactions:        
Equity consideration paid in connection with the Business Combination   167,300    
Initial measurement of warrants accounted for as a liability   36,200   16,200
Unpaid declared dividends   $ 2,445   2,449
Common stock issued to purchase noncontrolling interest       1,507
2020 Private Placement issuance cost accrued       381
At-the Market Equity Offering issuance cost accrued       $ 267
Repayment of long-term debt by Parent on behalf of the company $ 351,482